Pictor announces funding round after successful launch in New Zealand and USA of SARS-CoV-2 Antibody Test

Business Wire

Published

AUCKLAND, New Zealand--(BUSINESS WIRE)--Pictor, a global leader in immunodiagnostics, today announced a funding round to help accelerate pipeline product development projects along with market development activities within Australia/New Zealand, the US and Europe for its Human Health and Animal Health portfolios. This follows the recent successful launch of the PictArray™ SARS-CoV-2 IgG Antibody Test through Rako Science in New Zealand and key partners in the US. “The test better informs patien

Full Article